Skip to main content

Market Overview

50 Stocks Moving In Friday's Mid-Day Session

Share:

Gainers

  • Stellar Biotechnologies Inc (NASDAQ: SBOT) shares jumped 105 percent to $2.46 after the company reported a share exchange deal with Edesa Biotech.
  • TrovaGene, Inc. (NASDAQ: TROV) shares climbed 65.7 percent to $6.84 on continued strength after traders on Thursday circulated word of an FDA abstract document for the company's prostate cancer treatment; analysts at Maxim and Noble Financial reiterated bullish positions on the stock.
  • Seelos Therapeutics, Inc. (NASDAQ: SEEL) shares climbed 41.1 percent to $4.29 after surging 96.13 percent on Thursday. Seelos Therapeutics reported an offering for 15.96 million shares via selling shareholders.
  • Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) gained 37.9 percent to $2.95 after the company late Thursday announced a new European use patent for its TNX-601 PTSD treatment candidate.
  • Selecta Biosciences, Inc. (NASDAQ: SELB) climbed 27.6 percent to $2.59 after gaining 7.41 percent on Thursday.
  • SAExploration Holdings Inc (NASDAQ: SAEX) rose 24.5 percent to $4.5850 after the company announced $60 million of new projects in Alaska and Southeast Asia.
  • Nature's Sunshine Products, Inc. (NASDAQ: NATR) climbed 23.4 percent to $8.50 after the company reported Q4 EPS of $(0.15) compared to $(0.19) last year, and sales of $97.37 million, compared to $88.29 million last year.
  • DXP Enterprises, Inc. (NASDAQ: DXPE) surged 21.3 percent to $38.44 after the company reported Q4 EPS of $0.60, compared to $0.29 last year, and sales of $311 million, compared to $265.627 million last year.
  • AutoWeb, Inc. (NASDAQ: AUTO) gained 21 percent to $4.10 following Q4 results. B. Riley FBR upgraded AutoWeb from Neutral to Buy and raised the price target from $3.20 to $5.
  • Big Lots, Inc. (NYSE: BIG) shares rose 16.5 percent to $37.09 after the company reported higher-than-expected Q4 EPS results and announced a $50 million buyback.
  • Upland Software, Inc. (NASDAQ: UPLD) gained 15 percent to $38.84 after the company reported better-than-expected results for its fourth quarter.
  • Calithera Biosciences, Inc. (NASDAQ: CALA) shares rose 14.3 percent to $5.85 following Q4 results.
  • Celldex Therapeutics, Inc. (NASDAQ: CLDX) climbed 13.5 percent to $5.22 following strong Q4 results.
  • Myomo Inc (NYSE: MYO) gained 10.8 percent to $1.3299 after the company reported Q4 EPS and sales results above analyst estimates.
  • Red Lion Hotels Corporation (NYSE: RLH) shares climbed 10.4 percent to $8.20 after reporting Q4 results.
  • Neonode Inc. (NASDAQ: NEON) shares rose 9.5 percent to $2.65.
  • Phunware Inc. (NASDAQ: PHUN) shares gained 9.2 percent to $39.30.
  • IDT Corporation (NYSE: IDT) surged 9.1 percent to $6.23 following Q2 results.
  • Energy Recovery, Inc. (NASDAQ: ERII) gained 9.1 percent to $8.55 after the company reported higher-than-expected Q4 EPS and sales results.
  • Big Lots, Inc. (NYSE: BIG) shares rose 8.3 percent to $34.47 after reporting better-than-expected earnings for its fourth quarter.
  • Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) surged 7.2 percent to $3.57.
  • Vail Resorts, Inc. (NYSE: MTN) gained 6.8 percent to $216.10 after the company reported higher-than-expected Q2 EPS and sales results.
  • Costco Wholesale Corporation (NASDAQ: COST) rose 4.7 percent to $226.91 after the company reported stronger-than-expected earnings for its fiscal second quarter.
  • Horizon Pharma plc (NASDAQ: HZNP) rose 4.6 percent to $27.00. Morgan Stanley upgraded Horizon Pharma from Equal-Weight to Overweight.

 

Check out these big penny stock gainers and losers

Losers

  • CHF Solutions, Inc. (NASDAQ: CHFS) shares dropped 43.8 percent to $4.44 after the company filed for a $6.21 million offering.
  • Bio-Path Holdings, Inc. (NASDAQ: BPTH) dipped 34.3 percent to $25.55 in a potential sell off after the stock rose nearly 600 percent over the past few trading sessions.
  • Altimmune, Inc. (NASDAQ: ALT) shares fell 32.8 percent to $3.05 after surging 50.33 percent on Thursday. Altimmune reported a $14 million registered direct offering.
  • NV5 Global, Inc. (NASDAQ: NVEE) shares dropped 28.7 percent to $54.90 after the company reported lower-than-expected Q4 EPS and sales.
  • Eventbrite Inc (NYSE: EB) shares declined 25.3 percent to $24.23 after the company reported a wider-than-expected Q4 loss and issued weak earnings forecast.
  • China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) fell 24.2 percent to $3.3734.
  • AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) dipped 21.2 percent to $10.81 after the company reported topline results from its PROLONG trial did not demonstrate any statistically significant difference between the treatment and placebo arms for co-primary endpoints.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) declined 20.1 percent to $2.5099 following Q4 results.
  • Orion Engineered Carbons, S.A. (NYSE: OEC) shares fell 18.6 percent to $21.45 following Q4 results.
  • National Beverage Corp. (NASDAQ: FIZZ) dropped 18 percent to $56.00 after the company reported lower-than-expected Q3 EPS and sales results; Guggenheim analysts subsequently downgraded the company's stock from 'Neutral' to 'Sell'.
  • Great Elm Capital Group, Inc. (NASDAQ: GEC) shares declined 17.9 percent to $3.9000.
  • The Alkaline Water Company Inc. (NASDAQ: WTER) shares fell 16.4 percent to $2.6740 after the company priced a 4 million share common stock offering at $2.50 per share.
  • Bioblast Pharma Ltd. (NASDAQ: ORPN) shares dropped 15.5 percent to $13.02.
  • American Renal Associates Holdings, Inc. (NYSE: ARA) dipped 14.6 percent to $10.68 after the company announced a delay in its fourth quarter and full year 2018 earnings release.
  • El Pollo Loco Holdings, Inc. (NASDAQ: LOCO) shares dropped 14.1 percent to $12.93 after the company posted downbeat Q4 sales and issued weak FY19 earnings forecast.
  • Qualstar Corporation (NASDAQ: QBAK) shares fell 13.1 percent to $5.48 following Q4 results.
  • JMU Limited (NASDAQ: JMU) tumbled 12.7 percent to $2.40.
  • HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares fell 12.3 percent to $2.2885 after the company reported lower-than-expected Q4 sales and issued weak Q1 and FY19 guidance.
  • HCI Group, Inc. (NYSE: HCI) dipped 11.8 percent to $38.27 after reporting Q4 results.
  • Cleveland BioLabs, Inc. (NASDAQ: CBLI) shares declined 11.7 percent to $1.73.
  • Translate Bio, Inc. (NASDAQ: TBIO) shares fell 11.2 percent to $8.73.
  • Liquidia Technologies, Inc. (NASDAQ: LQDA) dipped 11.1 percent to $16.00.
  • California Resources Corporation (NYSE: CRC) shares dropped 9.9 percent to $19.21.
  • American Outdoor Brands Corp (NASDAQ: AOBC) fell 9.6 percent to $10.28 following the release of the company's Q3 earnings.
  • Korn Ferry (NYSE: KFY) shares fell 6.6 percent to $43.38 after reporting Q3 results.
  • Okta Inc (NASDAQ: OKTA) fell 4.4 percent to $77.68 after the company issued weak earnings guidance.
 

Related Articles (ALT + ADIL)

View Comments and Join the Discussion!

Posted-In: LosersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com